| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $715.1M | -1.9% |
| Cost of Revenue | $229.8M | +2.2% |
| Gross Profit | $485.3M | -3.7% |
| R&D Expense | $123.2M | -9.5% |
| SG&A Expense | $82.4M | -26.6% |
| Operating Income | $15.2M | +155.0% |
| Interest Expense | $28.9M | -27.5% |
| Pre-tax Income | -$24.1M | +62.4% |
| Income Tax | $3.1M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.0M | -24.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $49.7M | -15.8% |
| Current Assets | $203.9M | -17.7% |
| Total Assets | $683.2M | -9.6% |
| Current Liabilities | $169.2M | -1.9% |
| Long-term Debt | $350.0M | -14.6% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $63.6M | -19.5% |
| Capital Expenditures | $2.4M | -9.4% |
| Investing Cash Flow | -$16.4M | -292.2% |
| Financing Cash Flow | -$75.1M | +10.0% |
| Free Cash Flow | $61.2M | -19.9% |
| -13.5% |
| Net Income | -$27.2M | +59.7% |
| EPS (Basic) | -$0.21 | +62.5% |
| EPS (Diluted) | -$0.21 | +62.5% |
| Total Liabilities |
| $561.0M |
| -14.2% |
| Stockholders' Equity | $122.2M | +19.9% |